Device Trial Radar · NCT01401751
Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting
Last checked: Nov 19, 2026Latest source record: Feb 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Jul 1, 2011
Primary completion
Nov 1, 2011
Study completion Dec 1, 2011
Sponsor
- Lead sponsor
- Animas CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 25, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the performance of an insulin pump controlling algorithm while the subject is under close medical supervision in the Clinical Research Center (CRC) setting.
Conditions
- Type 1 Diabetes Mellitus
Interventions
Hypoglycemia-Hyperglycemia Minimizer SystemDevice
Hypoglycemia-Hyperglycemia Minimizer System, consisting of an subcutaneous insulin infusion pump, subcutaneous continuous glucose monitoring system, and a controller algorithm
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the performance of the System while the subject is under close medical supervision in the Clinical Research Center (CRC) setting.Time frame: End of Study - in approximately 5 months from first subject enrolled
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sansum Diabetes Research Institute
Santa Barbara, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.